These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38171343)

  • 21. Association of intraabdominal fat with the risk of incident chronic kidney disease according to body mass index among Korean adults.
    Lee J; Min S; Oh SW; Oh S; Lee YH; Kwon H; Lee CM; Choi HC; Heo NJ
    PLoS One; 2023; 18(2):e0280766. PubMed ID: 36757992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table.
    Cosentino F; Verma S; Ambery P; Treppendahl MB; van Eickels M; Anker SD; Cecchini M; Fioretto P; Groop PH; Hess D; Khunti K; Lam CSP; Richard-Lordereau I; Lund LH; McGreavy P; Newsome PN; Sattar N; Solomon S; Weidinger F; Zannad F; Zeiher A
    Eur Heart J; 2023 Oct; 44(39):4141-4156. PubMed ID: 37448181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials.
    Neuen BL; Oshima M; Agarwal R; Arnott C; Cherney DZ; Edwards R; Langkilde AM; Mahaffey KW; McGuire DK; Neal B; Perkovic V; Pong A; Sabatine MS; Raz I; Toyama T; Wanner C; Wheeler DC; Wiviott SD; Zinman B; Heerspink HJL
    Circulation; 2022 May; 145(19):1460-1470. PubMed ID: 35394821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity-related cardiorenal disease: the benefits of bariatric surgery.
    Fenske W; Athanasiou T; Harling L; Drechsler C; Darzi A; Ashrafian H
    Nat Rev Nephrol; 2013 Sep; 9(9):539-51. PubMed ID: 23917797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiorenal Nexus: A Review With Focus on Combined Chronic Heart and Kidney Failure, and Insights From Recent Clinical Trials.
    McCullough PA; Amin A; Pantalone KM; Ronco C
    J Am Heart Assoc; 2022 Jun; 11(11):e024139. PubMed ID: 35616212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thermogenic Modulation of Adipose Depots: A Perspective on Possible Therapeutic Intervention with Early Cardiorenal Complications of Metabolic Impairment.
    El-Yazbi AF; Elrewiny MA; Habib HM; Eid AH; Elzahhar PA; Belal ASF
    Mol Pharmacol; 2023 Nov; 104(5):187-194. PubMed ID: 37567782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease: JACC Review Topic of the Week.
    Morales J; Handelsman Y
    J Am Coll Cardiol; 2023 Jul; 82(2):161-170. PubMed ID: 37407115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes.
    Sridhar VS; Limonte CP; Groop PH; Heerspink HJL; Pratley RE; Rossing P; Skyler JS; Cherney DZI
    Diabetologia; 2024 Jan; 67(1):3-18. PubMed ID: 37801140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of cardiorenal complications in people with type 2 diabetes and obesity.
    Drucker DJ
    Cell Metab; 2024 Feb; 36(2):338-353. PubMed ID: 38198966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The new evidence on cardiorenal benefits of sodium-glucose cotransporter 2 inhibitors in type 1 diabetes: one step closer to their use in this setting?
    Popovic DS; Koufakis T; Patoulias D; Papanas N
    Expert Rev Clin Pharmacol; 2023; 16(11):1021-1023. PubMed ID: 37864783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists on Cardiorenal Outcomes: Systematic Review and Meta-analysis.
    Ali MU; Mancini GBJ; Fitzpatrick-Lewis D; Lewis R; Jovkovic M; Zieroth S; O'Meara E; Connelly KA; Sherifali D
    Can J Cardiol; 2022 Aug; 38(8):1201-1210. PubMed ID: 35961756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the treatment of patients with obesity and chronic kidney disease.
    Abdul Wahab R; Cohen RV; le Roux CW
    Ann Med; 2023 Dec; 55(1):2203517. PubMed ID: 37086110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mineralcorticoid receptor blockers in chronic kidney disease.
    Erraez S; López-Mesa M; Gómez-Fernández P
    Nefrologia (Engl Ed); 2021; 41(3):258-275. PubMed ID: 36166243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus.
    Sakurai T; Iimuro S; Araki A; Umegaki H; Ohashi Y; Yokono K; Ito H
    Gerontology; 2010; 56(2):141-9. PubMed ID: 19828932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minireview: Understanding and targeting inflammatory, hemodynamic and injury markers for cardiorenal protection in type 1 diabetes.
    Kugathasan L; Sridhar VS; Tommerdahl KL; Xu C; Bjornstad P; Advani A; Cherney DZI
    Metabolism; 2024 Apr; 153():155785. PubMed ID: 38215965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The emerging pillars of chronic kidney disease: no longer a bystander in metabolic medicine.
    Wonnacott A
    Clin Med (Lond); 2023 May; 23(3):254-258. PubMed ID: 37236791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiorenal syndrome and diabetes: an evil pairing.
    Méndez Fernández AB; Vergara Arana A; Olivella San Emeterio A; Azancot Rivero MA; Soriano Colome T; Soler Romeo MJ
    Front Cardiovasc Med; 2023; 10():1185707. PubMed ID: 37234376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of Type 2 Diabetes in Frail Older Adults.
    Bahat G; Ozkok S; Petrovic M
    Drugs Aging; 2023 Sep; 40(9):751-761. PubMed ID: 37434085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular and Kidney Risks in Individuals With Type 2 Diabetes: Contemporary Understanding With Greater Emphasis on Excess Adiposity.
    Sattar N; Presslie C; Rutter MK; McGuire DK
    Diabetes Care; 2024 Apr; 47(4):531-543. PubMed ID: 38412040
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.